Post-Marketing Experience of Edaravone in Amyotrophic Lateral Sclerosis: A Clinical Perspective and Comparison With the Clinical Trials of the Drug

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease that affects the upper and lower motor neurons. Currently, the only treatment for ALS is riluzole, which only has a limited effect on increasing survival from 3 to 6 months. New therapies are needed in the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz, Juan Fernando, Khan, Sawleha Arshi, Salem, Amr, Lin, Zayar, Iqbal, Zafar, Jahan, Nusrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645306/
https://www.ncbi.nlm.nih.gov/pubmed/33173626
http://dx.doi.org/10.7759/cureus.10818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645306/
https://www.ncbi.nlm.nih.gov/pubmed/33173626
http://dx.doi.org/10.7759/cureus.10818

Ejemplares similares